Definition
A corporate anti-takeover defence mechanism that allows existing shareholders (except the hostile bidder) to purchase additional shares at a steep discount if any single shareholder acquires above a threshold stake — dramatically diluting the hostile acquirer and making the takeover prohibitively expensive.
A poison pill (technically called a 'shareholder rights plan') is a pre-emptive defence against hostile takeovers. It typically works as follows: (a) the company's board adopts a rights plan; (b) if any person acquires more than X% of shares (the 'trigger'), all shareholders except the triggering person may purchase additional shares at a large discount (e.g., 50%); (c) the hostile acquirer is massively diluted — their existing stake is worth much less; (d) the takeover becomes prohibitively expensive — the acquirer must now buy many more shares to achieve control. Poison pills are not recognised under India's SEBI Takeover Code — Indian listed company boards have limited ability to adopt them due to SEBI's mandatory open offer regime and the duty of neutrality imposed on target company boards during open offers.
Statutory Definition
No statutory provision for poison pills in Indian law — they are more common in US/UK corporate practice. SEBI Takeover Regulations Regulation 26 imposes a 'board neutrality' obligation on target company boards during an open offer — boards cannot take actions that frustrate the offer without shareholder approval. This effectively prevents Indian listed companies from adopting US-style poison pills during a live takeover bid. However, pre-emptive provisions in Articles of Association (restrictions on share transfers, exit clauses) can serve similar defensive functions.
Etymology & Origin
The metaphor is dark: a 'poison pill' is something that makes the acquirer 'sick' — so costly and dilutive that they can't complete the acquisition without enormous financial pain. Swallowing the 'pill' (the triggering of the rights plan) poisons the acquisition economics.
Full Legal Analysis
Poison Pill: Making Hostile Takeover Too Expensive
Hostile takeovers threaten incumbent management but may benefit shareholders (if the offered price is fair). The poison pill is the board’s defence against this threat — by making itself too expensive to acquire. Whether this benefits shareholders (by forcing the acquirer to pay more) or harms them (by entrenching underperforming management) is the central corporate governance debate around poison pills.
Flip-In vs. Flip-Over
(a) Flip-in plan: If the acquirer crosses the trigger threshold, all shareholders (except the acquirer) can buy additional shares at a large discount — the acquirer is diluted. This is the most common form. (b) Flip-over plan: If the acquirer succeeds in merging the target into the acquirer, the target’s original shareholders can buy shares in the surviving (acquiring) entity at a discount — creating dilution in the acquirer.
India: Limited Defensive Options
Indian listed companies cannot adopt traditional poison pills because: (a) SEBI Takeover Code requires board neutrality during open offers; (b) New share issuances to defend against a takeover would likely require shareholder approval (which the hostile acquirer might block). Pre-emptive defensive measures (in the Articles): (a) Restrictions on share transfers to competitors; (b) Quorum requirements that entrench existing shareholders; (c) Classified boards (staggered director elections); (d) Supermajority voting requirements. None of these is a pure poison pill but they can slow down hostile acquisitions.
“The poison pill is the board saying: you can try to acquire us, but we’ll make it so expensive you’ll wish you hadn’t. Whether this protects shareholders (by forcing higher offers) or protects management (by entrenching underperformers) depends entirely on the quality of the board using it.”
